Cerebraim

EUIPO EUIPO 2020 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark Cerebraim was filed as Word mark on 07/03/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/18/2020. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018265632
Application date July 3, 2020
Publication date August 10, 2020
Entry date November 18, 2020
Expiration date July 3, 2030

Trademark owner

6th Floor, 25 Farringdon Street
EC4A 4AB London
GB

Trademark representatives

South Bank House, Barrow Street, D04TR29 Dublin 4 IE

goods and services

9 Computer software and programmes; computer software for scientific and medical analysis; downloadable computer software applications; computer software platforms; data processing apparatus; artificial intelligence software; artificial intelligence software for healthcare; artificial intelligence software for personalised medicines; software that provides medical assessment in real time based on artificial intelligence and using algorithm based machine learning technology; software for monitoring, analysing, controlling and running medical operations; downloadable electronic publications; downloadable teaching, instructional and educational material; electronic databases
42 Software as a service [SaaS]; platforms for artificial intelligence as software as a services [SaaS]; research in the field of artificial intelligence; providing on-line non-downloadable software in the field of biotechnology; software design and development services; computer programming; computer services; computer systems design and development; research relating to the development of computer programs and software; research, development and testing of software and algorithms for health care services; analysis of scientific data; authentication and testing services; scientific, pharmaceutical and medical research and development services; personalised medicine research and development services; research, design, development and testing of new products; pharmaceutical products research, design, development and testing; research, design, development and testing services in the field of biotechnology; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database and/or intranets and/or extranets and/or the Internet
44 Healthcare services; health risk assessments; pharmaceutical services; advisory services relating to pharmaceuticals; analysis of healthcare and medical data; medical testing for diagnostic or treatment purposes; providing medical testing and reporting services for the susceptibility, risk, diagnosis, prognosis, treatment and management of diseases; real time support medical services for medical decisions using algorithm-based machine learning; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database and/or intranets and/or extranets and/or the Internet

Trademark history

Date Document number Area Entry
January 8, 2021 Change Representative, Published

ID: 11018265632